
Study Shows Bevacizumab Improves Survival in Mesothelioma
A Phase 3 French study, which will be presented at the American Society of Clinical Oncology (ASCO)’s annual meeting at the end of May, demonstrated
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
A Phase 3 French study, which will be presented at the American Society of Clinical Oncology (ASCO)’s annual meeting at the end of May, demonstrated
by Melinda Kotzian, Chief Executive Officer, Mesothelioma Applied Research Foundation Over the last 24 hours, news broke that some cancer charities raised funds and did
by Sandy Robb Many of you have in previous years posted pictures about your travels around the country, and many seem to enjoy the national
On Thursday, May 14 at 8PM ET, the Meso Foundation will interview Drs. Evan Alley and Charles Simone of Penn Medicine during a new installment
by Carol Michaels Stretching is one of the basic components of fitness. Stretching improves your range of motion, which is the degree of movement that
Workers Memorial Day is held annually on April 28, and it consists of dozens of local events held all over the United States. More details
Watch Mary Hesdorffer, the Meso Foundation’s executive director and mesothelioma expert, in this opening presentation at the 2015 International Symposium on Malignant Mesothelioma. In this
The Meso Foundation is optimistic about the results of the Phase 1b trial of pembrolizumab for PD-L1-positive advanced solid tumors, which were announced at the
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!